An experimental single-dose vaccine uses the horsepox virus to harness the ... Nov. 7, 2024 — Increased capabilities for genomic surveillance have offered new insights into global viral evolution.

Whether or not you’ve received a COVID-19 vaccine in the past, it’s best to go into your appointment knowing what to expect. Keep reading to learn how to prepare your body for COVID-19 ...

“By advancing our investigational norovirus vaccine into a pivotal Phase 3 trial, we are one step closer to potentially providing a new tool to prevent infection from this highly contagious ...

Recent research has focused on the economic impact, immunogenicity, and safety of these vaccines, providing valuable insights into their effectiveness and public health implications. Recent ...

Vaccines protect babies and children from potentially life-threatening diseases. Widespread childhood vaccination has reduced or eliminated deadly diseases like polio and smallpox. Vaccines currently ...

In rare cases, hepatitis B can lead to life-threatening complications like liver failure, liver cancer, or cirrhosis (liver scarring). The hepatitis B vaccine is a shot, typically injected into the ...

Watterson says the new facilities at QEVC will enable his team to expand their work into arboviruses, such as dengue fever and Japanese encephalitis, which could help inform vaccine work in the ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases, which it plans to present at a scientific conference in the near future.

Respiratory syncytial virus (RSV) season often starts in the fall and peaks in winter. RSV vaccines are available to help reduce risk for severe illness. In many parts of the country, the fall season ...

The funding will see Afrigen’s researchers work with the International Vaccine Institute (IVI) to advance the mRNA candidate through preclinical testing and into a Phase I clinical trial in humans.